Isomerized Aβ in the brain can distinguish the status of amyloidosis in the Alzheimer's disease spectrum.
Saved in:
| Title: | Isomerized Aβ in the brain can distinguish the status of amyloidosis in the Alzheimer's disease spectrum. |
|---|---|
| Authors: | Mukherjee S; The Tracy Family SILQ Center, Washington University School of Medicine, St. Louis, MO, 63110, USA. msoumya@wustl.edu.; Department of Neurology, Washington University School of Medicine, St. Louis, MO, 63110, USA. msoumya@wustl.edu., Coyle R; The Tracy Family SILQ Center, Washington University School of Medicine, St. Louis, MO, 63110, USA.; Department of Neurology, Washington University School of Medicine, St. Louis, MO, 63110, USA., Dubois C; The Florey Institute of Neuroscience and Mental Health, 30 Royal Parade, Parkville, Victoria, 3052, Australia., Perez K; The Florey Institute of Neuroscience and Mental Health, 30 Royal Parade, Parkville, Victoria, 3052, Australia., McLean C; The Florey Institute of Neuroscience and Mental Health, 30 Royal Parade, Parkville, Victoria, 3052, Australia.; Department of Anatomical Pathology, Alfred Hospital, Prahran, Melbourne, Victoria, Australia, 3004., Masters CL; The Florey Institute of Neuroscience and Mental Health, 30 Royal Parade, Parkville, Victoria, 3052, Australia., Roberts BR; Department of Biochemistry, Emory University, Atlanta, GA, 30322, USA. blaine.roberts@emory.edu.; Department of Neurology, Emory University, Atlanta, GA, 30322, USA. blaine.roberts@emory.edu. |
| Source: | Acta neuropathologica [Acta Neuropathol] 2025 Jul 22; Vol. 150 (1), pp. 7. Date of Electronic Publication: 2025 Jul 22. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
